Fig. 5

(A) The brain tumour models were induced using the stereotaxic injection surgery. The tumours were confirmed with MR images prior to the MR-guided FUS treatment. Three weekly treatments were performed at the designed stage. (B) The procedure of sonodynamic therapy. In brief, the sonodynamic agent, 5-ALA, was administered intravenously 6Â h before the FUS sonication. (C) A representative treatment planning image was shown, and the FUS targets covering the tumour volume were placed.